APA (7th ed.) Citation

Wu, Z., Gourni, E., Ballal, S., Van der Veken, P., & Roesch, F. (2026). Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure–Function Relationships, and Preclinical Performance. Molecules, 31(12), 2124. https://doi.org/10.3390/molecules31122124

Chicago Style (17th ed.) Citation

Wu, Zhiyang, Eleni Gourni, Sanjana Ballal, Pieter Van der Veken, and Frank Roesch. "Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure–Function Relationships, and Preclinical Performance." Molecules 31, no. 12 (2026): 2124. https://doi.org/10.3390/molecules31122124.

MLA (9th ed.) Citation

Wu, Zhiyang, et al. "Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure–Function Relationships, and Preclinical Performance." Molecules, vol. 31, no. 12, 2026, p. 2124, https://doi.org/10.3390/molecules31122124.